Scient’x Announces Its Dynamic Solutions for the Spine Strategy and Concurrent Launch of Isobar Evolution

GUYANCOURT, France–(BUSINESS WIRE)–Scient’x Groupe S.A.S. (Scient’x) announces its focus on offering Dynamic Solutions for the spine. This corporate strategy positions Scient’x to be the worldwide leader in providing Dynamic Solutions for both non-fusion* and fusion procedures.

The cornerstone of the Scient’x Dynamic Solutions strategy is the Isobar Evolution^TM Dynamic Rod, which the company is introducing today as an adjunct to posterior pedicle-based fusion.

Scient’x President and CEO Oliver Burckhardt remarked, “We are very excited about introducing the Isobar Evolution^TM as a core technology in our new strategic approach. Thousands of patients around the globe have already been treated with Isobar Dynamic Rods, and with our demonstrated commitment to innovation and successful clinical outcomes, there is no company better equipped to apply the concept of Dynamic Fusion to the treatment of lower lumbar spine pathologies. The launch of the Isobar Evolution^TM will allow us to build on these years of successful clinical outcomes by investigating the product’s potential impact on adjacent level degeneration in the future.”

Dynamic Fusion, also known as semi-rigid fusion, immobilizes and stabilizes the spinal segment. It allows for load sharing across the fused construct and decreases stress at the screw interfaces when compared to rigid fusion.

The Isobar^TM Dynamic Rod, the predecessor to the new Isobar Evolution^TM Dynamic Rod, was the first semi-rigid rod introduced by Scient’x to the international market over 16 years ago. It has seen substantial clinical success as part of a Dynamic range for Scient’x.

“I have been using the semi-rigid dynamic interpedicular fixation system since June 1993, and my current personal experience is with more than 800 patients implanted. The justification for choosing such devices for my lumbar procedures was related to the quality of the biomechanical and clinical data that has accompanied this technology,” said Gilles Perrin, MD of Lyon, France.